Skip to content

The latest company news, press releases, and resources about Servier and everything our company has to offer.

Advanced Search
  • servier logo
     
    12.08.2023
    Servier Expands Base4 Partnership to Advance Neuroscience Drug Development
  • servier logo
     
    12.07.2023
    Nicolas Garnier joins Servier as Chief Patient Officer
  • servier logo
     
    12.05.2023
    Servier Data at ASH 2023 Furthers Leadership in Hard-to-Treat Hematologic Malignancies
  • servier logo
     
    12.05.2023
    Data at ASH 2023 Underscores Servier Leadership in Hard-to-Treat Hematologic Malignancies
  • servier logo
     
    11.18.2023
    New Analyses from Pivotal Phase 3 INDIGO Study Reinforce Vorasidenib's Potential to Change the Treatment Paradigm for IDH-Mutant Diffuse Glioma
Show 5102550100 per page
Media Contacts

Servier Media Relations
us2mediarelations@servier.com

Subscribe